Labeling and Biological Evaluation of (99m)Tc-HYNIC-Trastuzumab as a Potential Radiopharmaceutical for In Vivo Evaluation of HER2 Expression in Breast Cancer

The amplification of HER2 gene has been described in several tumor types, mainly breast cancer with a subsequent increase in HER2 protein expression. Trastuzumab is a humanized monoclonal antibody that recognizes selectively the HER2 extracellular domain. The objective of the present work was to sta...

Descripción completa

Detalles Bibliográficos
Autores principales: Calzada, Victoria, Garcia, Fernanda, Fernández, Marcelo, Porcal, Williams, Quinn, Thomas, Alonso, Omar, Gambini, Juan Pablo, Cabral, Pablo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3745630/
https://www.ncbi.nlm.nih.gov/pubmed/23961253
http://dx.doi.org/10.4103/1450-1147.113953

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3745630/
https://www.ncbi.nlm.nih.gov/pubmed/23961253
http://dx.doi.org/10.4103/1450-1147.113953

Ejemplares similares